Insmed Inc. buy Royal Bank of Canada
Start price
08.08.25
/
50%
€94.50
Target price
08.08.26
€102.90
Performance (%)
-4.72%
Price
29.07.26
€91.15
This prediction will end soon
Summary
This prediction is currently active. With a performance of -4.72%, the BUY prediction for Insmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 08.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1,01 % | 2,70 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % |
| iShares S&P 500 | -2,72 % | -1,75 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Royal Bank Of Canada from $108.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat